r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

MF

Meghan Fitzgerald

Insider · Director · ROIV

Meghan Fitzgerald files insider transactions with the SEC as a director of Roivant Sciences. We hold 3 disclosed purchases and sales filed since 11 January 2006, 2 of them in the last 90 days.

  • Files for 5 companiesROIV, THC, CNCE, CAH and 1 more
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure10 September 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 20 April 2023 — 8 September 2026Director · Roivant Sciences 26 Form 4 lines · source: SEC Form 4
  • Filed 31 May 2018 — 27 May 2026Director · Tenet Healthcare 20 Form 4 lines · source: SEC Form 4
  • Filed 22 March 2016 — 14 June 2018Director · Concert Pharmaceuticals 4 Form 4 lines · source: SEC Form 4
  • Filed 4 August 2015 — 17 November 2015EVP, Strategy & Health Policy · Cardinal Health 5 Form 4 lines · source: SEC Form 4
  • Filed 10 January 2006 — 12 March 2007VP and Chief Business Officer · Vion Pharmaceuticals 4 Form 4 lines · source: SEC Form 4

Every transaction

59 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
59 of 59 shown
8 Sep 202610 Sep 2026SEC Form 42 dexercised options overnot a tradeRoivant Sciences20,000 sharesdown −1.6%down −0.3%
8 Sep 202610 Sep 2026SEC Form 42 dsold on the open marketRoivant Sciences20,000 sharesdown −1.6%down −0.3%
8 Sep 202610 Sep 2026SEC Form 42 dexercised options overnot a tradeRoivant Sciencesderivative20,000 sharesdown −1.6%down −0.3%
30 Jun 20262 Jul 2026SEC Form 42 dexercised options overnot a tradeRoivant Sciences10,000 sharesup +15.3%up +16.2%
30 Jun 20262 Jul 2026SEC Form 42 dsold on the open marketRoivant Sciences10,000 sharesup +15.3%up +16.2%
30 Jun 20262 Jul 2026SEC Form 42 dexercised options overnot a tradeRoivant Sciencesderivative10,000 sharesup +15.3%up +16.2%
27 May 202628 May 2026SEC Form 41 dwas grantednot a tradeTenet Healthcarederivative1,188 sharesup +45.6%up +52.2%
22 May 202626 May 2026SEC Form 44 dexercised options overnot a tradeTenet Healthcare1,333 sharesup +51.7%up +49.5%
22 May 202626 May 2026SEC Form 44 dreturned to the issuernot a tradeTenet Healthcare493 sharesup +51.7%up +49.5%
22 May 202626 May 2026SEC Form 44 dexercised options overnot a tradeTenet Healthcarederivative1,333 sharesup +51.7%up +49.5%
26 Mar 202630 Mar 2026SEC Form 44 dexercised options overnot a tradeRoivant Sciences70,000 sharesup +49.3%up +54.6%
26 Mar 202630 Mar 2026SEC Form 44 dsold on the open marketRoivant Sciences70,000 sharesup +49.3%up +54.6%
26 Mar 202630 Mar 2026SEC Form 44 dexercised options overnot a tradeRoivant Sciencesderivative70,000 sharesup +49.3%up +54.6%
26 Mar 202630 Mar 2026SEC Form 44 dexercised options overnot a tradeRoivant Sciencesderivative70,000 sharesup +49.3%up +54.6%
26 Mar 202630 Mar 2026SEC Form 44 dexercised options overnot a tradeRoivant Sciences70,000 sharesup +49.3%up +54.6%
26 Mar 202630 Mar 2026SEC Form 44 dsold on the open marketRoivant Sciences70,000 sharesup +49.3%up +54.6%
10 Sep 202512 Sep 2025SEC Form 42 dwas grantednot a tradeRoivant Sciencesderivative33,726 sharesup +196.4%up +189.9%
10 Sep 202512 Sep 2025SEC Form 42 dwas grantednot a tradeRoivant Sciences14,524 sharesup +196.4%up +189.9%
10 Sep 202512 Sep 2025SEC Form 42 dacquired or disposed of, othernot a tradeRoivant Sciences937 sharesup +196.4%up +189.9%
23 May 202527 May 2025SEC Form 44 dexercised options overnot a tradeTenet Healthcarederivative1,551 sharesup +61.8%up +59.7%
23 May 202527 May 2025SEC Form 44 dexercised options overnot a tradeTenet Healthcare1,551 sharesup +61.8%up +59.7%
23 May 202527 May 2025SEC Form 44 dreturned to the issuernot a tradeTenet Healthcare573 sharesup +61.8%up +59.7%
22 May 202527 May 2025SEC Form 45 dwas grantednot a tradeTenet Healthcarederivative1,333 sharesup +63.4%up +59.7%
12 Sep 202416 Sep 2024SEC Form 44 dacquired or disposed of, othernot a tradeRoivant Sciences894 sharesup +236.8%up +239.0%
10 Sep 202412 Sep 2024SEC Form 42 dwas grantednot a tradeRoivant Sciencesderivative27,894 sharesup +234.9%up +236.8%
10 Sep 202412 Sep 2024SEC Form 42 dwas grantednot a tradeRoivant Sciences16,406 sharesup +234.9%up +236.8%
6 Aug 20248 Aug 2024SEC Form 42 dsold on the open marketTenet Healthcare20,000 sharesup +80.4%up +75.7%
23 May 202428 May 2024SEC Form 45 dwas grantednot a tradeTenet Healthcarederivative1,551 sharesup +104.4%up +101.5%
24 Apr 202426 Apr 2024SEC Form 42 dwas grantednot a tradeRoivant Sciences1,261 sharesup +274.5%up +270.1%
24 Apr 202426 Apr 2024SEC Form 42 dhad shares withheld for taxnot a tradeRoivant Sciences83 sharesup +274.5%up +270.1%
19 Jan 202423 Jan 2024SEC Form 44 dwas grantednot a tradeRoivant Sciences1,328 sharesup +294.4%up +290.6%
16 Oct 202318 Oct 2023SEC Form 42 dwas grantednot a tradeRoivant Sciences1,269 sharesup +300.6%up +313.6%
12 Sep 202314 Sep 2023SEC Form 42 dwas grantednot a tradeRoivant Sciencesderivative13,334 sharesup +263.8%up +255.3%
12 Sep 202314 Sep 2023SEC Form 42 dwas grantednot a tradeRoivant Sciences8,937 sharesup +263.8%up +255.3%
3 Jul 20236 Jul 2023SEC Form 43 dwas grantednot a tradeRoivant Sciences1,152 sharesup +318.2%up +283.3%
26 May 202323 Jun 2023SEC Form 428 dwas grantednot a tradeTenet Healthcare3,682 sharesup +275.1%up +237.2%
26 May 202330 May 2023SEC Form 44 dwas grantednot a tradeTenet Healthcare2,846 sharesup +275.1%up +274.7%
20 Apr 202324 Apr 2023SEC Form 44 dwas grantednot a tradeRoivant Sciencesderivative118,578 sharesup +363.9%up +360.2%
9 May 202211 May 2022SEC Form 42 dwas grantednot a tradeTenet Healthcare3,836 sharesup +271.7%up +277.8%
16 Sep 202120 Sep 2021SEC Form 44 dsold on the open marketTenet Healthcare6,077 sharesup +259.7%up +267.2%
24 May 202126 May 2021SEC Form 42 dsold on the open marketTenet Healthcare6,153 sharesup +314.5%up +307.1%
7 May 202111 May 2021SEC Form 44 dwas grantednot a tradeTenet Healthcare3,960 sharesup +294.5%up +303.9%
29 May 20202 Jun 2020SEC Form 44 dwas grantednot a tradeTenet Healthcare11,139 sharesup +1111.8%up +1092.6%
17 Mar 202018 Mar 2020SEC Form 41 dbought on the open marketTenet Healthcare6,153 sharesup +1905.2%up +2295.0%
3 May 20197 May 2019SEC Form 44 dwas grantednot a tradeTenet Healthcare10,817 sharesup +1132.2%up +1114.0%
14 Jun 201818 Jun 2018SEC Form 44 dwas grantednot a tradeCNCEConcert Pharmaceuticalsderivative10,000 shares——
14 Jun 201818 Jun 2018SEC Form 44 dwas grantednot a tradeCNCEConcert Pharmaceuticalsderivative3,453 shares——
31 May 20184 Jun 2018SEC Form 44 dwas grantednot a tradeTenet Healthcare7,912 sharesup +644.3%up +643.4%
15 Jun 201719 Jun 2017SEC Form 44 dwas grantednot a tradeCNCEConcert Pharmaceuticalsderivative10,000 shares——
22 Mar 201623 Mar 2016SEC Form 41 dwas grantednot a tradeCNCEConcert Pharmaceuticalsderivative25,000 shares——
17 Nov 201517 Nov 2015SEC Form 40 dhad shares withheld for taxnot a tradeCardinal Health260 sharesup +170.5%up +170.5%
15 Aug 201518 Aug 2015SEC Form 43 dwas grantednot a tradeCardinal Health3,362 sharesup +178.4%up +176.6%
15 Aug 201518 Aug 2015SEC Form 43 dhad shares withheld for taxnot a tradeCardinal Health4,085 sharesup +178.4%up +176.6%
15 Aug 201518 Aug 2015SEC Form 43 dwas grantednot a tradeCardinal Healthderivative16,164 sharesup +178.4%up +176.6%
4 Aug 20156 Aug 2015SEC Form 42 dwas grantednot a tradeCardinal Health7,818 sharesup +173.6%up +176.7%
12 Mar 200714 Mar 2007SEC Form 42 dwas grantednot a tradeVion Pharmaceuticals35,000 shares——
13 Dec 200615 Dec 2006SEC Form 42 dwas grantednot a tradeVion Pharmaceuticals360,000 shares——
10 Jan 200611 Jan 2006SEC Form 41 dwas grantednot a tradeVion Pharmaceuticals20,000 shares——
10 Jan 200611 Jan 2006SEC Form 41 dwas grantednot a tradeVion Pharmaceuticals140,000 shares——

Both percentages are the stock’s move, not Meghan Fitzgerald’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 51 of the 59 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.